Patents
Sitemap › C07 - Organic chemistry › C07K - Peptides › C07K 16 - Immunoglobulins, e.g. monoclonal or polyclonal antibodies
Patents for C07K 16 - Immunoglobulins, e.g. monoclonal or polyclonal antibodies (149,320)
11/2012
11/21/2012CN102786594A Sarsasapogenin monoclonal antibody and application
11/21/2012CN102786593A Anti-liriope muscari baily saponins C monoclonal antibody and application
11/21/2012CN102786592A Specific HBV antibody
11/21/2012CN102784391A IL-23 and its receptor
11/21/2012CN102181450B Trichina Ts27 gene, encoding protein and application thereof
11/21/2012CN102161983B Hybridoma cell line secreting I-IV-type dengue virus NS1 monoclonal antibodies and test kit thereof
11/21/2012CN101985476B Preparation, identification and application of antihuman NKp30 monoclonal antibody
11/21/2012CN101921335B Hybrid tumor generating anti-AMP-18 (Antrum Mucosalprotein-18) monoclonal antibody as well as anti-AMP-18 monoclonal antibody and application thereof in gastric carcinoma detection
11/21/2012CN101920004B Preparation and application of coconut globulin ferrous complex iron supplement agent
11/21/2012CN101914139B Human papilloma virus (HPV) capsid protein L1 polypeptide and preparation and application thereof
11/21/2012CN101602805B Agarose compatible medium for purifying immune globulin of hand-foot-and-mouth disease and preparation method thereof
11/21/2012CN101583624B Compositions and methods for diagnosing and treating cancer
11/21/2012CN101198374B Antibody or fragment thereof having anti-HIV neutralizing activity
11/20/2012USRE43823 Human monoclonal antibody against coreceptors for human immunodeficiency virus
11/20/2012US8314224 T1R taste receptors and genes encoding same
11/20/2012US8314213 Human equivalent monoclonal antibodies engineered from nonhuman variable regions
11/20/2012US8314212 Plasminogen receptor PLG-RKT and antibodies thereof
11/20/2012US8314211 Tissue sealant for use in non compressible hemorrhage
11/20/2012US8314208 Microwave enhanced N-fmoc deprotection in peptide synthesis
11/20/2012US8314069 Peptide nanostructures encapsulating a foreign material and method of manufacturing same
11/20/2012US8314059 Diabetic nephropathy therapies
11/20/2012US8313942 Compatible display vector systems
11/20/2012US8313927 Ucp4
11/20/2012US8313916 KID31 and antibodies that bind thereto
11/20/2012US8313913 Method of enhancing of binding activity of antibody composition to Fcγ receptor IIIa
11/20/2012US8313747 Antikine antibodies that bind to multiple CC chemokines
11/20/2012US8313745 Compositions against cancer antigen LIV-1 and uses thereof
11/20/2012CA2633171C Antibodies against tumor-associated antigenic target (tat) polypeptides
11/20/2012CA2585062C Identification of a jak2 mutation in polycythemia vera
11/20/2012CA2560278C Modified bouganin proteins, cytotoxins and methods and uses thereof
11/20/2012CA2426679C Preventive or therapeutic agent for psoriasis comprising il-6 antagonist as active ingredient
11/20/2012CA2421580C Discrimination between gnrh-i and gnrh-ii
11/20/2012CA2380331C Multiple cytokine-antibody complexes
11/20/2012CA2265915C Cxcr3 chemokine receptor, antibodies, nucleic acids, and methods of use
11/15/2012WO2012155134A2 Assay reagents for a neurogranin diagnostic kit
11/15/2012WO2012154999A1 Methods of treating or preventing cholesterol related disorders
11/15/2012WO2012154994A2 A novel adenovirus isolated from titi monkeys
11/15/2012WO2012154809A1 Compositions and methods for treating cancer
11/15/2012WO2012154530A1 Recombinant immunotoxin targeting mesothelin
11/15/2012WO2012154480A1 c-KIT ANTIBODIES AND USES THEREOF
11/15/2012WO2012154312A1 Neutralizing antibodies to hiv-1 and their use
11/15/2012WO2012154311A2 Focused evolution of hiv-1 neutralizing antibodies revealed by crystal structures and deep sequencing
11/15/2012WO2012153707A1 Antibody specifically recognising transferrin receptor
11/15/2012WO2012153126A1 Therapeutic canine immunoglobulins and methods of using the same
11/15/2012WO2012153123A1 Anti-nerve growth factor antibodies and methods of preparing and using the same
11/15/2012WO2012153122A1 Anti-nerve growth factor antibodies and methods of preparing and using the same
11/15/2012WO2012153121A1 Anti-nerve growth factor antibodies and methods of preparing and using the same
11/15/2012WO2012152716A1 Biochemical markers for cvd risk assessment
11/15/2012WO2012151702A1 Monoclonal antibody for acetylamantadine
11/15/2012WO2012151636A1 Actin binding agents
11/15/2012WO2012151609A1 Method of treatment and prophylaxis of pathologies of the bone
11/15/2012WO2012101252A3 Human antibodies to pcsk9 for use in methods of treating particular groups of subjects
11/15/2012WO2012097084A3 Tenomodulin (tnmd) isoforms and uses thereof
11/15/2012US20120289684 Methods of treating inflammation using soluble il-17ra/rc fusion proteins
11/15/2012US20120289680 Chromatography ligand comprising domain c from staphylococcus aureus protein a for antibody isolation
11/15/2012US20120289679 Novel mite allergen
11/15/2012US20120289468 Von willebrand factor (vwf)-containing preparations, and methods, kits, and uses related thereto
11/15/2012US20120289418 Diagnostic method and kit for the detection of a lymphocytic variant of hypereosinophilic syndrome
11/15/2012US20120288878 Methods for identifying immunobinders of cell-surface antigens
11/15/2012US20120288876 Novel identified oncogene with kinase-domain (nok)
11/15/2012US20120288871 Modified Carbocyanine Dyes and Their Conjugates
11/15/2012US20120288512 Anti-CD70 Antibody-Drug Conjugates and Their Use for the Treatment of Cancer and Immune Disorders
11/15/2012US20120288511 Glucagon/glp-1 receptor co-agonists
11/15/2012US20120288510 Human antibodies against hepatitis c virus (hcv) and uses thereof
11/15/2012US20120288508 Antibodies against clostridium difficile toxins and uses thereof
11/15/2012US20120288507 Wise binding agents and epitopes
11/15/2012US20120288506 C-kit antibodies and uses thereof
11/15/2012US20120288503 Polynucleotides and polypeptide sequences involved in the process of bone remodeling
11/15/2012US20120288502 Compositions and methods for improving potency and breadth of hiv antibodies
11/15/2012US20120288500 Human monoclonal antibodies to btla and methods of use
11/15/2012US20120288499 Methods for diagnosis and treatment of cutaneous t cell lymphomas
11/15/2012US20120288498 Polynucleotides and polypeptide sequences involved in cancer
11/15/2012US20120288494 Anti-IL-12/IL-23 antibodies and uses thereof
11/15/2012US20120288445 Radiolabelling
11/15/2012CA2835603A1 Antibody capable of specifically recognizing transferrin receptor
11/15/2012CA2835522A1 Focused evolution of hiv-1 neutralizing antibodies revealed by crystal structures and deep sequencing
11/15/2012CA2835506A1 Monoclonal antibody for acetylamantadine
11/15/2012CA2835294A1 Methods of treating or preventing cholesterol related disorders
11/15/2012CA2835203A1 Compositions and methods for treating cancer
11/15/2012CA2835200A1 C-kit antibodies and uses thereof
11/15/2012CA2835094A1 Anti-nerve growth factor antibodies and methods of preparing and using the same
11/15/2012CA2835092A1 Anti-nerve growth factor antibodies and methods of preparing and using the same
11/15/2012CA2835070A1 Recombinant immunotoxin targeting mesothelin
11/15/2012CA2834992A1 Therapeutic canine immunoglobulins and methods of using the same
11/15/2012CA2834983A1 Anti-nerve growth factor antibodies and methods of preparing and using the same
11/14/2012EP2522727A1 Highly functional bispecific antibody
11/14/2012EP2522724A1 Polypeptide modification method for purifying polypeptide multimers
11/14/2012EP2522678A1 Neutralizing antibodies to influenza viruses
11/14/2012EP2522364A1 Method of treating hemolytic disease
11/14/2012EP2522363A1 Method of treating hemolytic disease
11/14/2012EP2522362A1 Method of treating hemolytic disease
11/14/2012EP2522361A1 Method of treating hemolytic disease
11/14/2012EP2521789A2 Vectors and methods for transducing b cells
11/14/2012EP2521787A2 Enhanced protein expression
11/14/2012EP2521786A2 Compositions and methods for vaccinating against hsv-2
11/14/2012EP2521782A1 Flt3 receptor antagonists for the treatment or the prevention of pain disorders
11/14/2012EP2521737A1 Modified food grade microorganism for treatment of inflammatory bowel disease
11/14/2012EP2521736A1 Humanized antibodies
11/14/2012EP2521735A2 Recombinant human bivalent diabody against rabies virus and uses thereof
11/14/2012EP2521568A2 Plasma kallikrein binding proteins
1 ... 153 154 155 156 157 158 159 160 161 162 163 164 165 166 167 168 169 170 171 172 173 ... 1494